# Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

> **NCT00137371** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 480 (—)

## Conditions studied

- Atrophic Vaginitis
- Atrophy
- Vaginitis

## Interventions

- **DRUG:** PVC (daily for 21 days, 7 days off)
- **DRUG:** PVC (twice weekly)

## Key facts

- **NCT ID:** NCT00137371
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 480 (—)
- **Last updated:** 2007-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137371, "Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00137371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*